MODULATION EINER ANGIOPOIETIN-3-ÄHNLICHEN EXPRESSION

European patent · EP2521556 · In force

Register entry

Publication number
EP2521556
Application number
EP11732249
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 7, 2011
Published
Nov 14, 2012
Granted
May 30, 2018
Protection ends at the latest
Jan 6, 2031
Next annual fee due
Jan 31, 2027
IPC classes
A61K 31/7105 (2006.01)
C07H 21/02 (2006.01)
C12N 15/113 (2010.01)
Priority
US 293604 P 08.01.2010
PCT application
PCT/US2011/020606 07.01.2011
PCT publication
WO2011/085271 14.07.2011
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 1, 2026

    Change

    Published in Swissreg on 01.02.2026

  2. Feb 1, 2025

    Change

    Published in Swissreg on 01.02.2025

  3. Feb 1, 2024

    Change

    Published in Swissreg on 01.02.2024

  4. Dec 21, 2023

    Address changed

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 21.12.2023

  5. Feb 1, 2023

    Change

    Published in Swissreg on 01.02.2023

  6. May 30, 2018

    Granted

    Published in Swissreg on 30.05.2018

  7. May 30, 2018

    Agent entered

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in Swissreg on 30.05.2018

Parties

Inventor

CROOKE, Rosanne, M.

Carlsbad CA 92009, US

GRAHAM, Mark, J.

San Clemente CA 92672, US

LEE, Richard

Oceanside CA 92054, US

DOBIE, Kenneth, W.

Del Mar CA 92014, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.